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Korean Experimental protocol an inert vehicle, 10% gum arabic group I n 14 or irbesartan 50 mg/kg/day group II, n 12 was administered via feeding tube every 24 hours for 3 days before coronary occlusion. Animals were subjected to a 45-minute left coronary artery ligation followed by a 2-hour reperfusion. The rats were sacrificed and the left ventricle was excised for measurement of infarct size and biochemical analysis. 세포자멸 조절 물질의 변화 Fig. 5 . Light microscopic findings of TUNEL staining of non-ischemic A and ischemic myocardium of control B and irbesartan group C at 2 hours after reperfusion. TUNEL-positive cardiomyocytes arrows were frequently detected in the endocardial layer in control group. In contrast, only a few TUNEL-positive cardiomyocytes were detected mainly in the endocardial side close to the core of infarction in irbesartan group. TUNEL terminal deoxynucleotidyl transferasemediated dUTP-biotin nick end labeling technique.
Fig. 6.
The expression of Bcl-2 in normal and ischemic myocardium at 3 day-feeding with vehicle or irbesartan. No significant difference was found between the two groups in normal area, but higher expression was observed in ischemic area of the irbesartan group than that of the control group. CONT control, IRBST irbesartan.
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The expression of Bax in normal and ischemic myocardium at 3 day-feeding with vehicle or irbesartan. A slightly higher expression was detected in ischemic area than in normal area. No significant difference was found in ischemic area regardless of irbesartan administration. Last two lanes were from rats fed with control drug, hygenamine. CONT control, IRBST irbesartan.
Fig. 8.
The expression of ERK 1/2 in normal and ischemic myocardium at 3 day-feeding with vehicle or irbesartan. The general expression of ERK1 was attenuated in ischemic area compared to normal area. In ischemic area, irbesatan group showed increased expression of ERK1 compared to the control group. CONT control, IRBST irbesartan.
Fig. 9.
The expression of p-38 in normal and ischemic myocardium at 3 day-feeding with vehicle or irbesartan. The general expression of p-38 was attenuated in ischemic area. Irbesartan had no effect on the expression of p-38. CONT control, IRBST irbesartan. 
